Garin A M, Bazin I S
Ter Arkh. 1997;69(2):16-8.
The treatment of advanced gastric carcinoma is a challenge to oncologists. Within the last 6-7 years several new regimens have been introduced: EAP, FAMTX, MEP, MVP, ELF. Overall response rate of these schemes is 30-40%, a complete response seldom reaching 10%. Anticancer drugs significantly improve quality of life. Chemotherapy of advanced cancer is the method of choice. New combinations and regimens may appear promising.
晚期胃癌的治疗对肿瘤学家来说是一项挑战。在过去的6至7年里，已经引入了几种新的治疗方案：EAP、FAMTX、MEP、MVP、ELF。这些方案的总体缓解率为30%至40%，完全缓解率很少达到10%。抗癌药物显著提高了生活质量。晚期癌症的化疗是首选方法。新的联合用药和治疗方案可能很有前景。
